A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma

Wei Sen Lam, Jenette Creaney, Fred K. Chen, Wee Loong Chin, Sanjeevan Muruganandan, Sukanya Arunachalam, Mary S. Attia, Catherine Read, Kevin Murray, Michael Millward, Jon Spiro, Aron Chakera, Y. C. Gary Lee, Anna K. Nowak

Research output: Contribution to journalArticle

4 Citations (Scopus)

Search results